Processes and intermediates for preparing MCL1 inhibitors
US12202782B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2021 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Nov 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods and intermediates for the synthesis of certain compounds that inhibit MCL1, for use in the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.